Reported results
- Third quarter reported revenues of $411.2 million increased 2.3% on a reported basis and 2.5% on an organic basis compared to the prior year.
- Third quarter GAAP earnings per diluted share was $0.19, compared to $(0.07) in the prior year.
- Third quarter adjusted earnings per diluted share was $0.59, compared to $0.54 in the prior year.
- GAAP gross margin was 51.0%, compared to 51.5% in the third quarter of 2025.
- Adjusted gross margin was 61.1%, compared to 62.9% in the prior year.
- Adjusted EBITDA for the third quarter was $79.8 million, or 19.4% of revenue, compared to $78.5 million, or 19.5% of revenue, in the prior year.
Guidance
- For the fourth quarter of 2026, the company expects reported revenues in the range of $413 million to $433 million, representing a reported decline of -5.2% to -0.5% and an organic decline of -5.1% to -0.4%.
- For the fourth quarter of 2026, the company expects adjusted earnings per diluted share in the range of $0.61 to $0.71.
- For the full year 2026, the company expects revenues in the range of $1.634 billion to $1.654 billion, representing reported growth of -0.1% to 1.2% and organic growth of -0.3% to 0.9%.
- For the full year 2026, the company expects adjusted earnings per diluted share in the range of $2.30 to $2.40.
- For the full year 2026, the company continues to expect operating cash flow of approximately $190 million to $200 million.
Price and volatility reaction
The stock moved -11.2% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -4.9 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 13.33 | 2026-10-20 |
| Close after release | 11.84 | 2026-10-21 |
| Realised move | -11.2% | close to close |
| 30d ATM IV change | -4.9 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-10-21 (8-K, Item 2.02). Read the original filing on sec.gov.
